These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25210627)

  • 1. Anti-VEGF Cancer Therapy in Nephrology Practice.
    Izzedine H
    Int J Nephrol; 2014; 2014():143426. PubMed ID: 25210627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center.
    Izzedine H; Escudier B; Lhomme C; Pautier P; Rouvier P; Gueutin V; Baumelou A; Derosa L; Bahleda R; Hollebecque A; Sahali D; Soria JC
    Medicine (Baltimore); 2014 Nov; 93(24):333-339. PubMed ID: 25500702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal Antivascular Endothelial Growth Factor Therapy May Induce Proteinuria and Antibody Mediated Injury in Renal Allografts.
    Cheungpasitporn W; Chebib FT; Cornell LD; Brodin ML; Nasr SH; Schinstock CA; Stegall MD; Amer H
    Transplantation; 2015 Nov; 99(11):2382-6. PubMed ID: 25905984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature.
    Usui J; Glezerman IG; Salvatore SP; Chandran CB; Flombaum CD; Seshan SV
    Hum Pathol; 2014 Sep; 45(9):1918-27. PubMed ID: 25087655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury.
    Touzani F; Geers C; Pozdzik A
    Case Rep Nephrol; 2019; 2019():2919080. PubMed ID: 31934470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
    Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K
    BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy.
    Pfister F; Amann K; Daniel C; Klewer M; Büttner A; Büttner-Herold M
    Histopathology; 2018 Dec; 73(6):990-1001. PubMed ID: 30014486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF-VEGFR2 inhibitor-associated hyaline occlusive glomerular microangiopathy: a Japanese single-center experience.
    Ozawa M; Ohtani H; Komatsuda A; Wakui H; Takahashi N
    Clin Exp Nephrol; 2021 Nov; 25(11):1193-1202. PubMed ID: 34115234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study.
    Vigneau C; Lorcy N; Dolley-Hitze T; Jouan F; Arlot-Bonnemains Y; Laguerre B; Verhoest G; Goujon JM; Belaud-Rotureau MA; Rioux-Leclercq N
    Nephrol Dial Transplant; 2014 Feb; 29(2):325-32. PubMed ID: 24302609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic Microangiopathy and Acute Kidney Injury Induced After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors VEGF Blockade-Related TMA After Intravitreal Use.
    Hanna RM; Tran NT; Patel SS; Hou J; Jhaveri KD; Parikh R; Selamet U; Ghobry L; Wassef O; Barsoum M; Bijol V; Kalantar-Zadeh K; Pai A; Amin A; Kupperman B; Kurtz IB
    Front Med (Lausanne); 2020; 7():579603. PubMed ID: 33117836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bevacizumab-associated glomerular microangiopathy that occurred after postoperative chemotherapy for ovarian cancer.
    Morimoto M; Arai T; Matsuura M; Ono Y
    CEN Case Rep; 2021 Feb; 10(1):6-11. PubMed ID: 32642991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney injury during VEGF inhibitor therapy.
    den Deurwaarder ES; Desar IM; Steenbergen EJ; Mulders PF; Wetzels JF; van Herpen CM
    Neth J Med; 2012 Aug; 70(6):267-71. PubMed ID: 22859418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinuria and hypertension in patients treated with inhibitors of the VEGF signalling pathway--incidence, mechanisms and management.
    Tesařová P; Tesař V
    Folia Biol (Praha); 2013; 59(1):15-25. PubMed ID: 23537524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic Correlation with Renal Dysfunction after Intravitreal Injections of Vascular Endothelial Growth Factor Antagonists.
    Zhang PL; Raza S; Li W; Kanaan HD
    Ann Clin Lab Sci; 2021 Nov; 51(6):875-882. PubMed ID: 34921042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib.
    Bollée G; Patey N; Cazajous G; Robert C; Goujon JM; Fakhouri F; Bruneval P; Noël LH; Knebelmann B
    Nephrol Dial Transplant; 2009 Feb; 24(2):682-5. PubMed ID: 19054798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF inhibition and renal thrombotic microangiopathy.
    Eremina V; Jefferson JA; Kowalewska J; Hochster H; Haas M; Weisstuch J; Richardson C; Kopp JB; Kabir MG; Backx PH; Gerber HP; Ferrara N; Barisoni L; Alpers CE; Quaggin SE
    N Engl J Med; 2008 Mar; 358(11):1129-36. PubMed ID: 18337603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of anti-angiogenesis therapy: update for the internist.
    Gurevich F; Perazella MA
    Am J Med; 2009 Apr; 122(4):322-8. PubMed ID: 19332223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy.
    Suga S; Kim YG; Joly A; Puchacz E; Kang DH; Jefferson JA; Abraham JA; Hughes J; Johnson RJ; Schreiner GF
    Kidney Int; 2001 Oct; 60(4):1297-308. PubMed ID: 11576344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
    Yılmaz S; Özçakar ZB; Taktak A; Kiremitçi S; Ensari A; Dinçaslan H; Yalçınkaya F
    Pediatr Nephrol; 2016 Jun; 31(6):1029-32. PubMed ID: 26928310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nephrotoxicity of anti-angiogenesis drugs].
    Grechukhina KS; Chebotareva NV; Krasnova TN
    Ter Arkh; 2020 Jul; 92(6):93-98. PubMed ID: 33346501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.